GSK Statistics
Total Valuation
GSK plc has a market cap or net worth of $83.42 billion. The enterprise value is $99.56 billion.
Market Cap | 83.42B |
Enterprise Value | 99.56B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, before market open.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | Feb 22, 2024 |
Share Statistics
GSK plc has 2.03 billion shares outstanding.
Shares Outstanding | 2.03B |
Owned by Insiders (%) | 0.06% |
Owned by Institutions (%) | 14.85% |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 13.80 and the forward PE ratio is 10.32. GSK plc's PEG ratio is 1.09.
PE Ratio | 13.80 |
Forward PE | 10.32 |
PS Ratio | 2.18 |
Forward PS | 2.60 |
PB Ratio | 5.00 |
P/FCF Ratio | 12.18 |
PEG Ratio | 1.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.30, with an EV/FCF ratio of 14.53.
EV / Earnings | 15.96 |
EV / Sales | 2.59 |
EV / EBITDA | 12.30 |
EV / EBIT | 12.30 |
EV / FCF | 14.53 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 1.35.
Current Ratio | 0.89 |
Quick Ratio | 0.60 |
Debt / Equity | 1.35 |
Debt / EBITDA | 2.78 |
Debt / FCF | 3.29 |
Interest Coverage | 8.18 |
Financial Efficiency
Return on equity (ROE) is 38.70% and return on invested capital (ROIC) is 18.64%.
Return on Equity (ROE) | 38.70% |
Return on Assets (ROA) | 8.30% |
Return on Capital (ROIC) | 18.64% |
Revenue Per Employee | $546,771 |
Profits Per Employee | $88,845 |
Employee Count | 70,212 |
Asset Turnover | 0.51 |
Inventory Turnover | 1.61 |
Taxes
In the past 12 months, GSK plc has paid $945.18 million in taxes.
Income Tax | 945.18M |
Effective Tax Rate | 13.16% |
Stock Price Statistics
The stock price has increased by +14.42% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
Beta (1Y) | 0.27 |
52-Week Price Change | +14.42% |
50-Day Moving Average | 41.81 |
200-Day Moving Average | 37.94 |
Relative Strength Index (RSI) | 50.71 |
Average Volume (30 Days) | 3,491,038 |
Short Selling Information
Short Interest | 7.35M |
Short Previous Month | 3.97M |
Short % of Shares Out | 0.72% |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.57 |
Income Statement
In the last 12 months, GSK plc had revenue of $38.39 billion and earned $6.24 billion in profits. Earnings per share was $3.00.
Revenue | 38.39B |
Gross Profit | 27.21B |
Operating Income | 8.43B |
Pretax Income | 7.11B |
Net Income | 6.24B |
EBITDA | 8.10B |
EBIT | 8.10B |
Earnings Per Share (EPS) | $3.00 |
Balance Sheet
The company has $6.48 billion in cash and $22.53 billion in debt, giving a net cash position of -$16.05 billion or -$7.91 per share.
Cash & Cash Equivalents | 6.48B |
Total Debt | 22.53B |
Net Cash | -16.05B |
Net Cash Per Share | -$7.91 |
Equity / Book Value | 16.69B |
Book Value Per Share | 8.22 |
Working Capital | -3.03B |
Cash Flow
In the last 12 months, operating cash flow was $8.46 billion and capital expenditures -$1.61 billion, giving a free cash flow of $6.85 billion.
Operating Cash Flow | 8.46B |
Capital Expenditures | -1.61B |
Free Cash Flow | 6.85B |
FCF Per Share | $3.38 |
Margins
Gross margin is 70.88%, with operating and profit margins of 21.97% and 16.25%.
Gross Margin | 70.88% |
Operating Margin | 21.97% |
Pretax Margin | 18.51% |
Profit Margin | 16.25% |
EBITDA Margin | 21.09% |
EBIT Margin | 21.09% |
FCF Margin | 17.85% |
Dividends & Yields
This stock pays an annual dividend of $1.62, which amounts to a dividend yield of 3.94%.
Dividend Per Share | $1.62 |
Dividend Yield | 3.94% |
Dividend Growth (YoY) | 5.36% |
Years of Dividend Growth | n/a |
Payout Ratio | 54.02% |
Buyback Yield | -0.62% |
Shareholder Yield | 3.31% |
Earnings Yield | 7.47% |
FCF Yield | 8.21% |
Analyst Forecast
The average price target for GSK plc is $46.00, which is 11.90% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $46.00 |
Price Target Difference | 11.90% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 4.45% |
EPS Growth Forecast (5Y) | -4.75% |
Stock Splits
The last stock split was on July 22, 2022. It was a forward split with a ratio of 1226:1000.
Last Split Date | Jul 22, 2022 |
Split Type | Forward |
Split Ratio | 1226:1000 |
Scores
GSK plc has an Altman Z-Score of 1.87 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.87 |
Piotroski F-Score | 7 |